Related: Thrive Market Forced to Stop Selling CBD NPA Tells Congress: Regulate CBD, or Vaping Crisis Will Repeat NPA Submits Comments to FDA on NDIs and CBD
Daniel Fabricant, Ph.D., President and CEO of NPA, said in the release: “This is a win for legitimate businesses who are selling CBD products, but the bottom line is it doesn’t change the fact that congress needs to direct FDA to set a safe level of consumption for CBD. We will continue to work with the House and Senate to ensure that consumers have the information they need to make informed decisions about their health, especially when it comes to the fast-growing CBD marketplace.”